Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression
Advanced Science · 2026-01 · 13 (6)
DOI: 10.1002/advs.202507068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.11.2025. Verfasst von Zengbin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Receptor, Notch1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds Project for Innovation of Science and Technology, Fujian province, Fujian Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Nonerythrocytic alphaII‐spectrin (SPTAN1) is crucial for neuronal functions, yet its role in oncogenic processes remains inadequately characterized. This study investigates the lactylation (kla) modification of SPTAN1 (SPTAN1‐kla) and its mechanistic contributions to hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC). Results indicate that SPTAN1 undergoes lactylation at lysine residues K1952 and K1957 specifically in HBV‐positive HCC tissues. Alanyl‐tRNA synthetase 1 (AARS1) mediates SPTAN1‐kla formation, while histone deacetylase 1 (HDAC1) acts as a delactylase. HBV infection enhances lactate production by inducing the expression of HK2, promoting SPTAN1‐kla formation, and disrupting the liquid‐liquid phase separation (LLPS) of cytoplasmic SPTAN1, thereby facilitating its nuclear translocation. Within the nucleus, SPTAN1‐kla interacts with core‐binding factor β (CBFB) to activate NOTCH1/HES1 signaling, thereby promoting HCC cell proliferation. Furthermore, SPTAN1‐kla activates the COX2/mPGES1 pathway through NOTCH1/HES1 signaling, thereby enhancing the biosynthesis of prostaglandin E2 (PGE2) and increasing the infiltration of exhausted CD8⁺ T cells. Therapeutic targeting of SPTAN1‐kla using specific inhibitory peptides significantly attenuates HCC tumor growth in preclinical models. Our research identifies SPTAN1‐kla as a novel oncogenic driver in HBV‐related HCC, functioning via metabolic reprogramming and immune modulation. These findings position SPTAN1‐kla as a promising therapeutic target for developing precision interventions against HBV‐related HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China.
- Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fujian Medical University, Fujian, 350122, China.
- Cancer Center of Fujian Medical University, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
- Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, 350122, China.
- Key Laboratory of Clinical Laboratory Technology for Precision Medicine (Fujian Medical University), Fujian Province University, Fuzhou, 350122, China.
ORCID-Profile: Zengbin Wang, Nanhong Tang
Förderung
- National Natural Science Foundation of China
- Joint Funds Project for Innovation of Science and Technology, Fujian province
- Fujian Provincial Natural Science Foundation of China
- Startup grant for High-level Talents of Fujian Medical University
- High-Level Medical Care Construction Foundation of Fujian Province
Zitieren
APA
Wang, Z., Ye, D., Wu, L., Liu, J., Pan, B., Zhang, Z., Zhang, X., Yao, Y., & Tang, N. (2026). Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression. Advanced Science, 13(6). https://doi.org/10.1002/advs.202507068
Vancouver
Wang Z, Ye D, Wu L, Liu J, Pan B, Zhang Z, et al. Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression. Advanced Science. 2026;13(6). doi:10.1002/advs.202507068
BibTeX
@article{Wang2026,
author = {Wang, Zengbin and Ye, Dongjie and Wu, Linqing and Liu, Jiayu and Pan, Banglun and Zhang, Zhu and Zhang, Xiaoxia and Yao, Yuxin and Tang, Nanhong},
title = {Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {6},
doi = {10.1002/advs.202507068}
}
EUVIMED